These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38111708)

  • 1. Corn silk polysaccharides attenuate diabetic nephropathy through restoration of the gut microbial ecosystem and metabolic homeostasis.
    Dong W; Zhao Y; Li X; Huo J; Wang W
    Front Endocrinol (Lausanne); 2023; 14():1232132. PubMed ID: 38111708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating the gut microbiota and inflammation is involved in the effect of Bupleurum polysaccharides against diabetic nephropathy in mice.
    Feng Y; Weng H; Ling L; Zeng T; Zhang Y; Chen D; Li H
    Int J Biol Macromol; 2019 Jul; 132():1001-1011. PubMed ID: 30946910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sanziguben polysaccharides improve diabetic nephropathy in mice by regulating gut microbiota to inhibit the TLR4/NF-κB/NLRP3 signalling pathway.
    Wang F; Liu C; Ren L; Li Y; Yang H; Yu Y; Xu W
    Pharm Biol; 2023 Dec; 61(1):427-436. PubMed ID: 36772833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of the Gut Microbiota in Patients with Diabetic Nephropathy.
    Zhang L; Wang Z; Zhang X; Zhao L; Chu J; Li H; Sun W; Yang C; Wang H; Dai W; Yan S; Chen X; Xu D
    Microbiol Spectr; 2022 Aug; 10(4):e0032422. PubMed ID: 35863004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific Alternation of Gut Microbiota and the Role of
    Hong J; Fu T; Liu W; Du Y; Bu J; Wei G; Yu M; Lin Y; Min C; Lin D
    J Microbiol Biotechnol; 2024 Mar; 34(3):547-561. PubMed ID: 38346799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterorenal crosstalks in diabetic nephropathy and novel therapeutics targeting the gut microbiota.
    Ni Y; Zheng L; Nan S; Ke L; Fu Z; Jin J
    Acta Biochim Biophys Sin (Shanghai); 2022 Oct; 54(10):1406-1420. PubMed ID: 36239349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated molecular biology and metabonomics approach to understand the mechanism underlying reduction of insulin resistance by corn silk decoction.
    Dong W; Zhao Y; Hao Y; Sun G; Huo J; Wang W
    J Ethnopharmacol; 2022 Feb; 284():114756. PubMed ID: 34666141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corn silk (Zea mays L.), a source of natural antioxidants with α-amylase, α-glucosidase, advanced glycation and diabetic nephropathy inhibitory activities.
    Wang KJ; Zhao JL
    Biomed Pharmacother; 2019 Feb; 110():510-517. PubMed ID: 30530231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of gut microbiota in biopsy-proven diabetic nephropathy and a long history of diabetes without kidney damage.
    Lu X; Ma J; Li R
    Sci Rep; 2023 Jul; 13(1):12150. PubMed ID: 37500743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnesium lithospermate B ameliorates diabetic nephropathy by suppressing the uremic toxin formation mediated by gut microbiota.
    Zhu N; Duan H; Feng Y; Xu W; Shen J; Wang K; Liu J
    Eur J Pharmacol; 2023 Aug; 953():175812. PubMed ID: 37245856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tangshen formula modulates gut Microbiota and reduces gut-derived toxins in diabetic nephropathy rats.
    Zhao T; Zhang H; Yin X; Zhao H; Ma L; Yan M; Peng L; Wang Q; Dong X; Li P
    Biomed Pharmacother; 2020 Sep; 129():110325. PubMed ID: 32535383
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Zhou Q; Yang F; Li Z; Qu Q; Zhao C; Liu X; Yang P; Han L; Shi Y; Shi X
    J Med Microbiol; 2022 May; 71(5):. PubMed ID: 35617337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cordyceps cicadae polysaccharides ameliorated renal interstitial fibrosis in diabetic nephropathy rats by repressing inflammation and modulating gut microbiota dysbiosis.
    Yang J; Dong H; Wang Y; Jiang Y; Zhang W; Lu Y; Chen Y; Chen L
    Int J Biol Macromol; 2020 Nov; 163():442-456. PubMed ID: 32592781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition.
    Tao S; Li L; Li L; Liu Y; Ren Q; Shi M; Liu J; Jiang J; Ma H; Huang Z; Xia Z; Pan J; Wei T; Wang Y; Li P; Lan T; Tang X; Zeng X; Lei S; Tang H; Ma L; Fu P
    Acta Diabetol; 2019 May; 56(5):581-592. PubMed ID: 30888537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTZ polysaccharides ameliorate kidney injury in diabetic mice by regulating gut-kidney axis.
    Lan T; Tang T; Li Y; Duan Y; Yuan Q; Liu W; Ren Y; Li N; Liu X; Zhang Y; Li X; Jin G; Wang S; Guo J
    Phytomedicine; 2023 Sep; 118():154935. PubMed ID: 37364420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intake of total saponins and polysaccharides from Polygonatum kingianum affects the gut microbiota in diabetic rats.
    Yan H; Lu J; Wang Y; Gu W; Yang X; Yu J
    Phytomedicine; 2017 Mar; 26():45-54. PubMed ID: 28257664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium lithospermate B improves the gut microbiome and bile acid metabolic profiles in a mouse model of diabetic nephropathy.
    Zhao J; Zhang QL; Shen JH; Wang K; Liu J
    Acta Pharmacol Sin; 2019 Apr; 40(4):507-513. PubMed ID: 29941869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
    Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
    Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
    [No Abstract]   [Full Text] [Related]  

  • 19. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. San-Huang-Yi-Shen Capsule Ameliorates Diabetic Nephropathy in Rats Through Modulating the Gut Microbiota and Overall Metabolism.
    Su X; Yu W; Liu A; Wang C; Li X; Gao J; Liu X; Jiang W; Yang Y; Lv S
    Front Pharmacol; 2021; 12():808867. PubMed ID: 35058786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.